Since aPL and anti-PF4 antibodies were reported in few COVID-19 patients (12, 17) and anti-PF4 antibodies have been associated with the development of VITT after ChAdOx1 vaccination (13–15), we detected the abovementioned autoantibodies in our cohort of vaccinated healthcare workers. The gene discussed is FASLG; the disease is COVID-19.